Allscripts' UK Growth Recognised in KLAS EMR Report

AllscriptsAllscripts’ rapid growth in the UK and high levels of customer satisfaction have been recognised in a KLAS performance report into the European electronic medical record market. The independent research, which tracks contract wins and the views of healthcare professionals about vendors and products, says Europe is 'one of the most dynamic and competitive EMR markets in the world.'

In this environment, Allscripts has gone from having one English customer for its Sunrise electronic patient record in 2011, to eight today.

KLAS reports that the five go-lives covered by its research "have progressed successfully". It also summarises structured interviews with customers by saying: "Customers like the product and feel it is powerful and can do a lot. Customers are generally pleased with what they have achieved."

Steven Brain, vice president and managing director, UK, Allscripts, said: "This is an exciting time for healthcare IT in England. We have a new health and social care secretary who has made technology one of his three priorities, and a new ten year-plan for the NHS in development that will be 'digitally enabled at its heart'.

"Trusts are looking for digitisation partners to support their electronic patient record ambitions and help them share information and insights across increasingly integrated healthcare economies. So, it is good to see that KLAS has recognised the progress made by Allscripts, and the confidence of our customers in our product and team.

"We are the only company that can provide a clinical wrap for trusts that enables them to retain their patient administration system and core IT investments, while adding key clinical functionality. The KLAS research shows trusts can be confident in this approach."

The KLAS report is based on market intelligence and interviews with healthcare professionals about the products and services they use. The interviews are conducted using a standard quantitative evaluation methodology, from which performance scores can be calculated.

Allscripts was given an overall performance score of 80.1 out of 100 for the UK and Ireland; significantly above the market average. It scored particularly well on 'quality of implementation' (7.4 on a nine-point scale), overall quality of product (7.4), and forecasted overall satisfaction (7.6).

Nine out of ten customers interviewed said they would buy Sunrise again (89%) and that it was part of their long-term plan (90%). All the customers interviewed expressed confidence in cost (100% said Allscripts avoided unexpected costs).

In interviews, customers also praised the support they received from the Allscripts team in the UK, with comments including: "Allscripts was good during our entire implementation", "we have been working really well with them and are very happy with them", "other vendors sign on the dotted line and kind-of disappear, but that is not the case with Allscripts" and "Allscripts keep their promises whenever they can."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Artificial Intelligence Detects a New Cl…

Many mutations in DNA that contribute to disease are not in actual genes but instead lie in the 99% of the genome once considered "junk." Even though scientists have recently...

Essen University Medicine and Siemens He…

The Essen University Medicine, Germany's leading hospital company for digitalized medicine, and Siemens Healthineers, a world-leading medical technology company, plan to work together to develop the hospital of the future...

Final Cohort Selected For Pioneering Dig…

Propel@YH has announced the six start-ups to participate in its inaugural digital health accelerator programme, aimed at navigating the complex healthcare landscape and building an NHS-relevant business case. The Leeds-based...

New Kid on the Block: The Doctrina Acade…

The Doctrina Academy is a new service, developed by Doctrina, a video e-learning platform that reaches over 1,000,000 healthcare professionals (HCPs) from around the globe, helping them to switch ...

Efficacy and SilverCloud Health Supports…

A leading mental health service is using the digital mental health platform developed by SilverCloud Health to support a confidential NHS service for GPs in England. London-based Efficacy is offering...

Gloucestershire Hospitals to Deliver EPR…

Gloucestershire Hospitals NHS Foundation Trust is moving to a 'clinical wrap' strategy to deliver an electronic patient record (EPR) and achieve the highest levels of digital maturity within five-years. The...

Mobile Phone App Designed to Boost Physi…

Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone...

Application Period for an International …

The Master of Science (M.Sc.)in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

NHS Prescribing is Back in the Spotlight…

Opinion Article by Dr Simon Hendricks, Product Innovation Manager and Clinical Strategy Lead, FDB (First Databank) Political will for better and safer prescribing in the NHS has fast gained momentum in...

Sectra to Provide Large Centralized Regi…

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year contract with North Tees and Hartlepool NHS Foundation Trust for the delivery of a regional...

IMI to Boost Patient Involvement in its …

The Innovative Medicines Initiative (IMI) is creating a 'pool' of patient experts to strengthen the role and voice of patients in IMI activities at both strategic and operational levels. IMI...